Related Experiment Videos
[Limulus test (factor G pathway) positive substance during cardiopulmonary bypass]
T Nakajima1, M Mukaida, K Ishibashi
1Department of Third Surgery, Iwate Medical University, Morioka, Japan.
Nihon Geka Gakkai Zasshi
|December 1, 1994
Summary
Cardiopulmonary bypass (CPB) activates the Limulus cascade reaction, primarily through factor G pathway reactive activity (GPRA), not endotoxin. This GPRA activation originates from patient tissues, especially in aortic aneurysm and ischemic heart disease cases during CPB.
Area of Science:
- Biochemistry
- Immunology
- Cardiovascular Surgery
Context:
- The Limulus cascade reaction is frequently activated during cardiopulmonary bypass (CPB).
- Recent evidence suggests factor G pathway reactive activity (GPRA) is the primary activator, rather than endotoxin.
- Understanding the source of GPRA is crucial for managing CPB-related complications.
Purpose:
- To investigate circulating endotoxin and GPRA levels in patients undergoing CPB.
- To differentiate the roles of endotoxin and GPRA in Limulus cascade activation during CPB.
- To identify potential origins of GPRA during CPB procedures.
Summary:
- This study measured plasma endotoxin and GPRA in 32 patients undergoing CPB, categorized by diagnosis.
- Highest GPRA concentrations were observed at the end of CPB, with endotoxin levels remaining normal.
- GPRA levels were significantly higher in patients with aortic dissection and ischemic heart disease compared to valve or congenital heart disease, suggesting tissue origin.
Impact:
- Findings indicate that patient tissues, not the CPB circuit, are the likely source of GPRA during CPB.
- This research could lead to improved strategies for mitigating inflammatory responses during CPB.
- Highlights the importance of considering GPRA in patients undergoing complex cardiac surgeries.